VC firms back €20m series-A for Stipe

Novo Holdings co-led the round with Arix, and Wellington Partners and Sunstone Ventures also took part.

Arix's Christian Schetter and Jonathan Tobin will join Stipe's board of directors.

Previous funding
Stipe span out from Aarhus University, Denmark, in 2018 with the support of a pre-seed grant from Novo Nordisk Foundation. It subsequently took a convertible loan from BioInnovation Institute (Novo Nordisk Foundation's biotech incubator initiative).

Company
Stipe was founded in 2018 and is headquartered in Aarhus. It is a biotechnology firm working on harnessing the immune response to target a range of tumours, both directly and in combination with other anti-tumour agents.

People
Stipe Therapeutics – Claus Elsborg Olesen (CEO).

• Tweet  
• Facebook  
• LinkedIn  
• Google plus  
• Send to  

• Topics
• Early-stage
• Nordics
• Healthcare
• Denmark
• Sunstone Capital A/S
• Wellington Partners